can i take prednisone with semaglutide Structure of (subcutaneous formulation) Semaglutide Telehealth: Get a Prescription

Conditions that typically exclude GLP-1 candidacy - and that Omzo's clinical intake process is designed to screen for - include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), a history of pancreatitis, and known hypersensitivity to semaglutide or any component of the medication

This risk increases if you experience vomiting or diarrhea

Although GLP-1 patches are not currently licensed in the UK, the following guidance applies broadly to transdermal medication systems and would be relevant should such products become available

Enter your ZIP code to compare prices

Patients with multiple endocrine neoplasia syndrome type 2 (MEN 2) or a history of thyroid cancer should not use Semaglutide